S. Singh, A. M. Allen, Z. Wang, L. J. Prokop, M. H. Murad et al., Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies, Clin Gastroenterol Hepatol, vol.13, p.649, 2015.

M. Sayiner, A. Koenig, L. Henry, and Z. M. Younossi, Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world, Clin Liver Dis, vol.20, pp.205-214, 2016.

Z. M. Younossi, A. Koenig, D. Abdelatif, Y. Fazel, L. Henry et al., Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, vol.64, pp.73-84, 2016.

R. J. Wong, R. Cheung, and A. Ahmed, Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the, Hepatology, vol.59, pp.2188-2195, 2014.

S. H. Ibrahim, P. Hirsova, H. Malhi, and G. J. Gores, Animal models of nonalcoholic steatohepatitis: eat, delete, and inflame, Dig Dis Sci, vol.61, pp.1325-1336, 2016.

M. V. Machado, G. A. Michelotti, G. Xie, A. Pereira, T. Boursier et al., Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease, PLoS One, vol.10, p.127991, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01392325

H. Itagaki, K. Shimizu, S. Morikawa, K. Ogawa, and T. Ezaki, Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice, Int J Clin Exp Pathol, vol.6, pp.2683-2696, 2013.

M. Charlton, A. Krishnan, K. Viker, S. Sanderson, S. Cazanave et al., Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition, Am J Physiol Gastrointest Liver Physiol, vol.301, pp.825-834, 2011.

A. Asgharpour, S. C. Cazanave, T. Pacana, M. Seneshaw, R. Vincent et al., A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer, J Hepatol, vol.65, pp.579-588, 2016.

D. Scholten, J. Trebicka, C. Liedtke, and R. Weiskirchen, The carbon tetrachloride model in mice, Lab Anim, vol.49, pp.4-11, 2015.

N. Kubota, S. Kado, M. Kano, N. Masuoka, Y. Nagata et al., A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with nonalcoholic steatohepatitis in mice, Clin Exp Pharmacol Physiol, vol.40, pp.422-430, 2013.

S. De-minicis, L. Agostinelli, C. Rychlicki, G. P. Sorice, S. Saccomanno et al., HCC development is associated to peripheral insulin resistance in a mouse model of NASH, PLoS One, vol.9, p.97136, 2014.

D. E. Kleiner, E. M. Brunt, M. Van-natta, C. Behling, M. J. Contos et al., Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, vol.41, pp.1313-1321, 2005.

S. Lee, R. Muniyappa, X. Yan, H. Chen, L. Q. Yue et al., Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice, Am J Physiol Endocrinol Metab, vol.294, pp.261-270, 2008.

J. E. Bowe, Z. J. Franklin, A. C. Hauge-evans, A. J. King, S. J. Persaud et al., Metabolic phenotyping guidelines: assessing glucose homeostasis in rodent models, J Endocrinol, vol.222, pp.13-25, 2014.

P. G. Engstrom, T. Steijger, B. Sipos, G. R. Grant, A. Kahles et al., Systematic evaluation of spliced alignment programs for RNA-seq data, Nat Methods, vol.10, pp.1185-1191, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00909047

M. D. Robinson and A. Oshlack, A scaling normalization method for differential expression analysis of RNA-seq data, Genome Biol, vol.11, p.25, 2010.

A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, vol.102, pp.15545-15550, 2005.

A. Liberzon, C. Birger, H. Thorvaldsdottir, M. Ghandi, J. P. Mesirov et al., The Molecular Signatures Database (MSigDB) hallmark gene set collection, Cell systems, vol.1, pp.417-425, 2015.

C. A. Moylan, H. Pang, A. Dellinger, A. Suzuki, M. E. Garrett et al., Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease, Hepatology, vol.59, pp.471-482, 2014.

M. Ahrens, O. Ammerpohl, V. Schonfels, W. Kolarova, J. Bens et al., DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery, Cell Metab, vol.18, pp.296-302, 2013.

S. Nakagawa, L. Wei, W. M. Song, T. Higashi, S. Ghoshal et al., Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition, Cancer Cell, vol.30, pp.879-890, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02312659

Y. Hoshida, S. M. Nijman, M. Kobayashi, J. A. Chan, J. P. Brunet et al., Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma, Cancer Res, vol.69, pp.7385-7392, 2009.

I. Mederacke, C. C. Hsu, J. S. Troeger, P. Huebener, X. Mu et al., Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology, Nat Commun, vol.4, p.2823, 2013.

M. M. Richardson, J. R. Jonsson, E. E. Powell, E. M. Brunt, B. A. Neuschwander-tetri et al., Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction, Gastroenterology, vol.133, pp.80-90, 2007.

V. L. Gadd, R. Skoien, E. E. Powell, K. J. Fagan, C. Winterford et al., The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease, Hepatology, vol.59, pp.1393-1405, 2014.

S. Maeda, H. Kamata, J. L. Luo, H. Leffert, and M. Karin, IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis, Cell, vol.121, pp.977-990, 2005.

M. Salomao, W. M. Yu, R. S. Brown, J. C. Emond, and J. H. Lefkowitch, Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH, Am J Surg Pathol, vol.34, pp.1630-1636, 2010.

A. Teufel, T. Itzel, W. Erhart, M. Brosch, X. Y. Wang et al., Comparison of gene expression patterns between mouse models of nonalcoholic fatty liver disease and liver tissues from patients, Gastroenterology, vol.151, pp.513-525, 2016.

M. Kobori, S. Masumoto, Y. Akimoto, and H. Oike, Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice, Mol Nutr Food Res, vol.55, pp.530-540, 2011.

C. Dorn, J. C. Engelmann, M. Saugspier, A. Koch, A. Hartmann et al., Increased expression of c-Jun in nonalcoholic fatty liver disease, Lab Invest, vol.94, pp.394-408, 2014.

S. C. Kim, C. K. Kim, D. Axe, A. Cook, M. Lee et al., All-trans-retinoic acid ameliorates hepatic steatosis in mice by a novel transcriptional cascade, Hepatology, vol.59, pp.1750-1760, 2014.

E. Y. Kwon, S. K. Shin, Y. Y. Cho, U. J. Jung, E. Kim et al., Time-course microarrays reveal early activation of the immune transcriptome and adipokine dysregulation leads to fibrosis in visceral adipose depots during diet-induced obesity, BMC Genomics, vol.13, p.450, 2012.

W. Hur, J. H. Lee, S. W. Kim, J. H. Kim, S. H. Bae et al., Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acidinduced proinflammatory cytokine production through the AMPK/AKT pathway, Int J Biochem Cell Biol, vol.64, pp.265-276, 2015.

Y. Kita, T. Takamura, H. Misu, T. Ota, S. Kurita et al., Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis, PLoS One, vol.7, p.43056, 2012.

V. Tryndyak, A. De-conti, T. Kobets, K. Kutanzi, I. Koturbash et al., Interstrain differences in the severity of liver injury induced by a choline-and folate-deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism, FASEB J, vol.26, pp.4592-4602, 2012.

I. Frades, E. Andreasson, J. M. Mato, E. Alexandersson, R. Matthiesen et al., Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic Fatty liver disease, PLoS One, vol.10, p.124544, 2015.

W. C. Tsai, S. D. Hsu, C. S. Hsu, T. C. Lai, S. J. Chen et al., MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis, J Clin Invest, vol.122, pp.2884-2897, 2012.

J. S. Yang, J. T. Kim, J. Jeon, H. S. Park, G. H. Kang et al., Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice, PLoS One, vol.5, p.13858, 2010.

C. Ma, A. H. Kesarwala, T. Eggert, J. Medina-echeverz, D. E. Kleiner et al., NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis, Nature, vol.531, pp.253-257, 2016.

M. C. Wallace, S. L. Friedman, and D. A. Mann, Emerging and disease-specific mechanisms of hepatic stellate cell activation, Semin Liver Dis, vol.35, pp.107-118, 2015.

Y. A. Lee, M. C. Wallace, and S. L. Friedman, Pathobiology of liver fibrosis: a translational success story, Gut, vol.64, pp.830-841, 2015.

M. V. Machado, G. A. Michelotti, T. A. Pereira, G. Xie, R. Premont et al., Accumulation of duct cells with activated YAP parallels fibrosis progression in NonAlcoholic Fatty Liver Disease, J Hepatol, vol.63, pp.962-970, 2015.

J. R. Clapper, M. D. Hendricks, G. Gu, C. Wittmer, C. S. Dolman et al., Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment, Am J Physiol Gastrointest Liver Physiol, vol.305, pp.483-495, 2013.

J. K. Dowman, L. J. Hopkins, G. M. Reynolds, N. Nikolaou, M. J. Armstrong et al., Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle, Am J Pathol, vol.184, pp.1550-1561, 2014.

D. E. Kleiner and H. R. Makhlouf, Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children, Clin Liver Dis, vol.20, pp.293-312, 2016.

R. Urtasun, A. Lopategi, J. George, T. M. Leung, Y. Lu et al., Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin alpha(V)beta(3) engagement and PI3K/pAkt/NFkappaB signaling, Hepatology, vol.55, pp.594-608, 2012.

C. Savard, E. V. Tartaglione, R. Kuver, W. G. Haigh, G. C. Farrell et al., Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis, Hepatology, vol.57, pp.81-92, 2013.

D. Q. Wang, F. Lammert, D. E. Cohen, B. Paigen, and M. C. Carey, Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis, Am J Physiol, vol.276, pp.751-760, 1999.

P. Puri, R. A. Baillie, M. M. Wiest, F. Mirshahi, J. Choudhury et al., A lipidomic analysis of nonalcoholic fatty liver disease, Hepatology, vol.46, pp.1081-1090, 2007.

F. Caballero, A. Fernandez, D. Lacy, A. M. Fernandez-checa, J. C. Caballeria et al., Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH, J Hepatol, vol.50, pp.789-796, 2009.

X. Wang, Z. Zheng, J. M. Caviglia, K. E. Corey, T. M. Herfel et al., Hepatocyte TAZ/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis, Cell Metab, vol.24, pp.848-862, 2016.

M. N. Kristiansen, S. S. Veidal, K. T. Rigbolt, K. S. Tolbol, J. D. Roth et al., Obese diet-induced mouse models of nonalcoholic steatohepatitistracking disease by liver biopsy, World J Hepatol, vol.8, pp.673-684, 2016.